1-3 of 3
Andreas Draube
Close
Sort by
Journal Articles

CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants

Michael von Bergwelt-Baildon, Alexander Shimabukuro-Vornhagen, Alexey Popov, Nela Klein-Gonzalez, Francesca Fiore, Svenja Debey, Andreas Draube, Britta Maecker, Isaura Menezes, Lee M. Nadler, Joachim L. Schultze
Journal: Blood
Blood (2006) 107 (7): 2786–2789.
https://doi.org/10.1182/blood-2004-01-0113
Published: 2006
Includes: Supplemental data
Journal Articles

A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo

Elke Pogge von Strandmann, Hinrich P. Hansen, Katrin S. Reiners, Roland Schnell, Peter Borchmann, Sabine Merkert, Venkateswara R. Simhadri, Andreas Draube, Marcel Reiser, Ingvill Purr, Michael Hallek, Andreas Engert
Journal: Blood
Blood (2006) 107 (5): 1955–1962.
https://doi.org/10.1182/blood-2005-05-2177
Published: 2006
Journal Articles

PEG-Interferon for Chronic Phase CML - Still an Option in the Era of Imatinib?.

Christof Scheid, MD, Andreas Draube, MD, Udo Holtick, MD, Oliver Cornely, MD, Ulrich Hacker, MD, Michael Fuchs, MD, Ute Berger, MD, Andreas Hochhaus, MD, PhD, Rüdiger Hehlmann, MD, PhD, Michael Hallek, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4662.
https://doi.org/10.1182/blood.V104.11.4662.4662
Published: 2004